ridinilazole: Clinical Trials

4 trials of ridinilazole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2
Phase 32Completed 1, Terminated 1

Follow ridinilazole: new trials by email Literature Review of ridinilazole trials Research Report on ridinilazole

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects
Ridinilazole, Vancomycin - Clostridioides Difficile Infection
Phase 3TerminatedSummit Therapeutics22021-05-192023-08-21
Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Ridinilazole, Vancomycin - Clostridioides Difficile Infection
Phase 3CompletedSummit Therapeutics7592019-01-282026-10-09
A Study of Ridinilazole (SMT19969) Compared With Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI)
Ridinilazole, Fidaxomicin - Clostridium Difficile Infection
Phase 2CompletedSummit Therapeutics272014-12-012017-10-12
A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)
SMT19969, Vancomycin - Clostridium Difficile Infection
Phase 2CompletedSummit Therapeutics1002014-04-012016-10-20

Conditions studied

Clostridium Infections (4)  ·  Diarrhea (1)  ·  Infections (1)

Sponsors

Summit Therapeutics (4)

Countries

United States (4)  ·  Canada (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Czechia (1)  ·  Greece (1)  ·  Hungary (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Romania (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)

Top investigators

Lori Styles, MD (2)  ·  Richard Vickers, PhD (1)

Results publications

PMID 28461207, PMID 29718329, PMID 30767587, PMID 38305378